固体大麻素可以解释CBD介导的血压降低吗? 来自随机,安慰剂控制,交叉试验的见解
Marko Kumric1,2, Goran Dujic3, Josip Vrdoljak1,2
1Department of Pathophysiology, University of Split School of Medicine, Split, Croatia.
Cannabis and cannabinoid research
|November 7, 2025
概括
在患有高血压的患者中,大麻素 (CBD) 补充剂增加了安纳米德 (AEA) 水平. 然而,AEA的这些变化并不能解释CBD降血压的作用.
科学领域:
- 心血管药理学心血管药理学
- 内类大麻素系统研究研究
- 高血压治疗药物 高血压治疗药物
背景情况:
- HYPER-H21-4试验表明,慢性大麻 (CBD) 在高血压患者中降低血压 (BP).
- 内分泌大麻素 (EC) 系统与高血压有关,这促使人们对其在CBD心血管作用中的作用进行调查.
研究的目的:
- 调查是否循环内分泌素 (ECs) 的变化调解了CBD降血压的作用.
- 为了确定慢性CBD给药对安纳胺 (AEA) 和2-阿拉基多诺伊尔糖醇 (2-AG) 的血水平的影响.
主要方法:
- 一个随机的,安慰剂控制的交叉试验,涉及66名患有初级高血压的患者.
- 患者接受了CBD (225-450毫克/天) 或安慰剂5周,随后是交叉期.
- 在整个研究期间,与血压监测一起,测量了血AEA和2-AG水平.
主要成果:
- 与安慰剂相比,慢性CBD的使用显著增加了血AEA水平.
- 在AEA水平的变化和静缩血压的变化之间没有发现显著的关联.
- 长期使用CBD并没有显著改变血2-AG度.
结论:
- 在高血压患者中,CBD补充会增加循环AEA水平.
- 观察到的AEA水平的增加并不能明确解释CBD降血压的作用.
- 需要进一步的研究来阐明CBD抗高血压作用背后的精确机制.
更多相关视频
相关概念视频
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
Neural Regulation of Blood Pressure
6.8K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
6.8K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
657
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
657
Antihypertensive Drugs: Action of β1 Blockers
1.9K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.9K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K


